EULAR NEWS

Read the latest:

  • EULAR Recommendations for the management of Psoriatic Arthritis with pharmacological therapies: 2023 update
  • 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice
  • EULAR recommendations for the nonpharmacological core management of hip and knee osteoarthritis: 2023 update
  • 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases 



 
 Discover


Read the latest:

  • Latest Update for Psoriatic Arthritis
  • Press Registration is open for the EULAR 2024 Congress
  • ​New: Recommendations for Imaging in Crystal-Induced Arthropathies
  • New: Points to Consider in Hyperinflammation

 


 




Discover

  

EULAR and BMJ are announcing a change to their longstanding joint ownership of the prestigious medical journals Annals of Rheumatic Diseases (ARD)  and RMD Open. As part of this transition, EULAR will take full ownership of ARD, while BMJ will wholly own RMD Open. ​   BMJ will continue to publish and distribute both journals, while EULAR will exclusively focus on the development of ARD. BMJ will focus on the development of RMD Open as part of its growing portfolio of open access journal titles. This change marks the beginning of an exciting new chapter in the journals’ histories, which will remain focused on advancing rheumatology research and care.


Discover  

EULAR NEWSLETTER
EULAR COMMUNITIES
EULAR CALENDAR UPCOMING EVENTS


@EULAR_ORG